Literature DB >> 29857993

What can we learn about COPD from impulse oscillometry?

Brian J Lipworth1, Sunny Jabbal2.   

Abstract

Impulse oscillometry (IOS) is the most commonly used type of forced oscillation technique in clinical practice, although relatively little is known about its application in COPD. Resistance at 20 Hz (R20) is unrelated to COPD severity and does not improve with bronchodilatation or bronchoconstriction, inferring a lack of large airway involvement in COPD. Peripheral airway resistance expressed as frequency dependent heterogeneity between 5 Hz and 20 Hz (R5-R20), and peripheral airway compliance as area under the reactance curve (AX), are both closely related to COPD severity and exacerbations. Both R5-R20 and AX markedly improve in response to long acting bronchodilators, while AX appears to be more sensitive than R5-R20 in response to bronchoconstriction. Future studies may be directed to assess if IOS in combination with spirometry is more sensitive at predicting future exacerbations. Perhaps AX might also be useful as a screening tool in early stage disease or to monitor long term decline in COPD.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COPD; FOT; IOS; Oscillometry; Reactance; Resistance

Mesh:

Year:  2018        PMID: 29857993     DOI: 10.1016/j.rmed.2018.05.004

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  10 in total

1.  The Role of Airway Shunt Elastance on the Compartmentalization of Respiratory System Impedance.

Authors:  Jason H T Bates
Journal:  J Eng Sci Med Diagn Ther       Date:  2019-01-18

2.  The Pressing Need to Redefine "COPD".

Authors:  Peter J Barnes; Jørgen Vestbo; Peter M Calverley
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11

Review 3.  Lung Function Assessment by Impulse Oscillometry in Adults.

Authors:  Noemi Porojan-Suppini; Ovidiu Fira-Mladinescu; Monica Marc; Emanuela Tudorache; Cristian Oancea
Journal:  Ther Clin Risk Manag       Date:  2020-11-26       Impact factor: 2.423

4.  Discordant Spirometry and Impulse Oscillometry Assessments in the Diagnosis of Small Airway Dysfunction.

Authors:  Lifei Lu; Jieqi Peng; Ningning Zhao; Fan Wu; Heshen Tian; Huajing Yang; Zhishan Deng; Zihui Wang; Shan Xiao; Xiang Wen; Youlan Zheng; Cuiqiong Dai; Xiaohui Wu; Kunning Zhou; Pixin Ran; Yumin Zhou
Journal:  Front Physiol       Date:  2022-06-22       Impact factor: 4.755

Review 5.  Oscillometry of the respiratory system: a translational opportunity not to be missed.

Authors:  Lennart K A Lundblad; Annette Robichaud
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-04-06       Impact factor: 5.464

6.  I Say IOS You Say AOS: Comparative Bias in Respiratory Impedance Measurements.

Authors:  Chris RuiWen Kuo; Sunny Jabbal; Brian Lipworth
Journal:  Lung       Date:  2019-07-04       Impact factor: 2.584

7.  Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease.

Authors:  Sundeep S Salvi; Bill B Brashier; Jyoti Londhe; Kanchan Pyasi; Vandana Vincent; Shilpa S Kajale; Sajid Tambe; Kuldeep Mandani; Arjun Nair; Sze Mun Mak; Sapna Madas; Sanjay Juvekar; Louise E Donnelly; Peter J Barnes
Journal:  Respir Res       Date:  2020-02-12

Review 8.  Catching "Early" COPD - The Diagnostic Conundrum.

Authors:  Kay Por Yip; Robert A Stockley; Elizabeth Sapey
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-04-13

9.  Assessing Static Lung Hyperinflation by Whole-Body Plethysmography, Helium Dilution, and Impulse Oscillometry System (IOS) in Patients with COPD.

Authors:  Michela D'Ascanio; Fausta Viccaro; Noemi Calabrò; Giulio Guerrieri; Claudia Salvucci; Dario Pizzirusso; Rita Mancini; Claudia De Vitis; Aldo Pezzuto; Alberto Ricci
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-21

Review 10.  Early Diagnosis and Real-Time Monitoring of Regional Lung Function Changes to Prevent Chronic Obstructive Pulmonary Disease Progression to Severe Emphysema.

Authors:  Tony Jung; Neeraj Vij
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.